As part of its continued commitment to serving Northeastern University’s innovation community, Northeastern University’s Center for Research Innovation (CRI) participated in AdvaMed, the premier medical devices, diagnostic products and health information systems in September.

Northeastern ‘s reputation for relevant innovation is continuing to draw interest, a trend which was evident  at AdvaMed 2012.  Leading the translation of University innovations to high impact solutions through entrepreneurship and commercialization strategies, CRI contributed to the visibility of the research and academic community in the Massachusetts Pavilion.  The Pavilion showcased some of the ‘best and brightest’ the state has to offer to the global medical technology industry, punctuated by the presence of Governor Patrick.

Tracey Dodenhoff, Founding Director, CRI, met with a wide range of entities from the medical technology ecosystem, including MassBio, MassMEDIC, Johnson and Johnson, and Toyota Tsusho. Conversations set the path for future collaborations as well as provided engaging exchange around the technological advances and opportunities in the medical field.

A key outcome of CRI’s participation in AdvaMed 2012 is an invitation to the EU-US eHealth Marketplace, sponsored by the US Department of Health and Human Resources (DHHS) and the European Commission DG Connect (EC) to foster trans-Atlantic business endeavors in the healthcare and health IT sectors.

About Northeastern University’s Center for Research Innovation
Northeastern University’s Center for Research Innovation (CRI) is a catalyst for the transformation of Northeastern’s use-inspired innovations into high impact solutions. CRI has a wide range of life science technologies available for licensing, including portfolios of small molecules for therapeutic use; nano and microparticle compositions for therapeutic and/or diagnostic applications; devices for therapeutic and preventive use, diagnostics tailored to in-clinic and at home use; tools and equipment for research and clinical applications; and software for diagnostic and individualized wellness assessments.

About AdvaMed
In its 6th year, AdvaMed 2012 provided a unique environment for its member companies to meet and foster relationships leading to collaborations and investments.  These member companies produce medical devices, diagnostic products and health information systems that are transforming health care through early disease detection, less invasive procedures and more effective treatments.  AdvaMed 2012 participants represented 22 countries and took place October 1-3 in Boston, MA.